Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effect of Trikafta on bone density, body composition and exercise capacity in CF: A pilot study
Authors
Keywords
-
Journal
PEDIATRIC PULMONOLOGY
Volume 58, Issue 2, Pages 577-584
Publisher
Wiley
Online
2022-11-14
DOI
10.1002/ppul.26243
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Assessment of the determinants of changes and test–retest reliability in the 6-min walk test performance over a 4-month period in healthy 6–12-year-old children
- (2022) Tamara del Corral et al. EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY
- Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles
- (2022) Simon Y. Graeber et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Peripheral muscle strength is associated with aerobic fitness and use of antibiotics in patients with cystic fibrosis
- (2021) Fernanda Maria Vendrusculo et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- Rapid Improvement After Starting Elexacaftor-tezacaftor-ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease
- (2021) Pierre-Régis Burgel et al. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE
- Body composition and weight changes after ivacaftor treatment in adults with cystic fibrosis carrying the G551 D cystic fibrosis transmembrane conductance regulator mutation: A double-blind, placebo-controlled, randomized, crossover study with open-label extension
- (2021) Susannah J. King et al. NUTRITION
- The association between body composition, leptin levels and glucose dysregulation in youth with cystic fibrosis
- (2021) Andrea Granados et al. Journal of Cystic Fibrosis
- Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor Therapy in Three Subjects with the Cystic Fibrosis Genotype Phe508del/Unknown and Advanced Lung Disease
- (2021) Vito Terlizzi et al. Genes
- Effectiveness and safety of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease with the Phe508del/minimal function genotype
- (2021) Vincenzo Carnovale et al. RESPIRATORY MEDICINE
- Body composition in individuals with cystic fibrosis
- (2021) Sarah Soltman et al. Journal of Clinical and Translational Endocrinology
- Changes in LCI in F508del/F508del patients treated with lumacaftor/ivacaftor: Results from the prospect study
- (2020) Michelle Shaw et al. Journal of Cystic Fibrosis
- Understanding the interplay between factors that influence bone mineral density in CF
- (2020) Michal Gur et al. PEDIATRIC PULMONOLOGY
- Effect of CFTR Modulators on Anthropometric Parameters in Individuals with Cystic Fibrosis: An Evidence Analysis Center Systematic Review
- (2020) Julianna Bailey et al. Journal of the Academy of Nutrition and Dietetics
- The Effects of Ivacaftor on Bone Density and Microarchitecture in Children and Adults with Cystic Fibrosis
- (2020) Melissa S Putman et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Cardiopulmonary responses to maximal aerobic exercise in patients with cystic fibrosis
- (2019) Craig A. Williams et al. PLoS One
- Longitudinal assessment of exercise capacity and quality of life outcome measures in cystic fibrosis: A year-long prospective pilot study
- (2019) Rajeev Bhatia et al. JOURNAL OF EVALUATION IN CLINICAL PRACTICE
- Lumacaftor/ Ivacaftor improves exercise tolerance in patients with Cystic Fibrosis and severe airflow obstruction
- (2019) Peter A. B. Wark et al. BMC Pulmonary Medicine
- Laboratory performance of sweat conductivity for the screening of cystic fibrosis
- (2018) Ronda F. Greaves et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Energy Balance and Mechanisms of Weight Gain with Ivacaftor Treatment of Cystic Fibrosis Gating Mutations
- (2018) Virginia A. Stallings et al. JOURNAL OF PEDIATRICS
- Cystic fibrosis, body composition, and health outcomes: a systematic review
- (2018) Patrizia Calella et al. NUTRITION
- Nutritional status and pulmonary outcome in children and young people with cystic fibrosis
- (2018) Niovi Papalexopoulou et al. RESPIRATORY MEDICINE
- VX-445–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and One or Two Phe508del Alleles
- (2018) Dominic Keating et al. NEW ENGLAND JOURNAL OF MEDICINE
- Bone demineralization is improved by ivacaftor in patients with cystic fibrosis carrying the p.Gly551Asp mutation
- (2016) Isabelle Sermet-Gaudelus et al. Journal of Cystic Fibrosis
- Breakthrough therapies: Cystic fibrosis (CF) potentiators and correctors
- (2015) George M. Solomon et al. PEDIATRIC PULMONOLOGY
- An official European Respiratory Society/American Thoracic Society technical standard: field walking tests in chronic respiratory disease
- (2014) Anne E. Holland et al. EUROPEAN RESPIRATORY JOURNAL
- Consensus statement for inert gas washout measurement using multiple- and single- breath tests
- (2013) Paul D. Robinson et al. EUROPEAN RESPIRATORY JOURNAL
- Lung clearance index: Evidence for use in clinical trials in cystic fibrosis
- (2013) L. Kent et al. Journal of Cystic Fibrosis
- Lung clearance index: Normal values, repeatability, and reproducibility in healthy children and adolescents
- (2009) Susanne I. Fuchs et al. PEDIATRIC PULMONOLOGY
- A novel sidestream ultrasonic flow sensor for multiple breath washout in children
- (2008) Susanne I. Fuchs et al. PEDIATRIC PULMONOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search